Concepedia

Alejandro Schcolnik‐Cabrera

AS

Statistics

Publications

16

Citations

606

H-Index

13

Active since

2014

Affiliations

Instituto Nacional de Cancerología(Current)

Universidad Nacional Autónoma de México

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

Hôpital Maisonneuve-Rosemont

Clínica Ruiz

Alejandro Schcolnik‐Cabrera is an author at Instituto Nacional de Cancerología specializing in medicine, cancer therapeutics, and health sciences.

ORCID

Top concepts

Publications per year

2014–2024

16

Publications

16

The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug.

Mandy Juárez, Alejandro Schcolnik‐Cabrera, Alfonso Dueñas‐González · PubMed · 2018 · 184 citations

Genistein stimulates insulin sensitivity through gut microbiota reshaping and skeletal muscle AMPK activation in obese subjects

Martha Guevara‐Cruz, Einar T Godinez-Salas, Mónica Sánchez‐Tapia et al. · BMJ Open Diabetes Research & Care · 2020 · 100 citations · Full text

Understanding tumor anabolism and patient catabolism in cancer-associated cachexia.

Alejandro Schcolnik‐Cabrera, Alma Chávez‐Blanco, Guadalupe Domínguez-Gómez et al. · PubMed · 2017 · 56 citations · Full text

, , +12

Perspectives on Drug Repurposing

Alejandro Schcolnik‐Cabrera, Daniel Juárez-López, Alfonso Dueñas‐González · Current Medicinal Chemistry · 2020 · 39 citations

, , +17

Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug

Mandy Juárez, Alejandro Schcolnik‐Cabrera, Guadalupe Domínguez-Gómez et al. · Cancer Chemotherapy and Pharmacology · 2020 · 38 citations

, , +10

1–5 of 16